Align Technology (BSP:A1LG34) 3-Year EBITDA Growth Rate : 19.80% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Align Technology 3-Year EBITDA Growth Rate?

Align Technology's EBITDA per Share for the three months ended in Mar. 2024 was R$3.09.

During the past 12 months, Align Technology's average EBITDA Per Share Growth Rate was 15.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 19.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Align Technology was 45.20% per year. The lowest was 8.30% per year. And the median was 23.00% per year.

Competitive Comparison of Align Technology's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Align Technology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Align Technology's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Align Technology's 3-Year EBITDA Growth Rate falls into.

Align Technology 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Align Technology (BSP:A1LG34) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Align Technology 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Align Technology's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology (BSP:A1LG34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (BSP:A1LG34) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ALGN:USA ALGN:Mexico AFW:Germany AFW:Germany

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.

Align Technology (BSP:A1LG34) Headlines

No Headlines